An examination of payer coverage for multiple sclerosis drugs shows variation in how these drugs are covered and in the evidence that payers review to make these decisions.
Pallavi Rane, PhD
Advertisement
Articles by Pallavi Rane, PhD
Advertisement
Latest Updated Articles
- Variation in the Coverage of Disease-Modifying Multiple Sclerosis Drugs Among US Payers
Published: September 21st 2017 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Therapeutic Cancer Vaccines: Are We There Yet?
2
FDA Approves Gazyva for Active Lupus Nephritis
3
Walgreens Strengthens Vaccine Access Through Digital Tools, Pharmacist Education
4
In the Fragmented Landscape of Long COVID Care, Pharmacists Are Essential
5
